Lv0
0 积分 2025-02-17 加入
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
17天前
已完结
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
17天前
已完结
Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
18天前
已完结
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
18天前
已完结
Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody
19天前
已完结
Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma
19天前
已完结
WHO WINS THE WAR AGAINST DIABETES? COMPARATIVE EFFICACY OF TIRZEPATIDE, SEMAGLUTIDE, AND PLACEBO IN DIABETES CONTROL: A NETWORK META-ANALYSIS
9个月前
已关闭
Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study
9个月前
已完结
Dose-Response Relationship of GLP-1 Receptor Agonists on HbA1c and Body Weight in Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis
9个月前
已完结
COMPARATIVE EFFICACY OF TIRZEPATIDE, SEMAGLUTIDE, AND PLACEBO IN WEIGHT MANAGEMENT: A NOVEL NETWORK META-ANALYSIS
9个月前
已完结
皖公网安备34019202002308
